{
    "2018-10-31": [
        [
            {
                "time": "2018-11-05",
                "original_text": "Eli Lilly (LLY) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead",
                "features": {
                    "keywords": [
                        "Pharmaceuticals Industry",
                        "Stock Outlook",
                        "Steady Path"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Sanofi's (SNY) Q3 Earnings and Sales Surpass Estimates",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Q3 Earnings",
                        "Sales",
                        "Surpass Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "XLV, MDT, ABT, LLY: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "XLV",
                        "MDT",
                        "ABT",
                        "LLY",
                        "ETF Inflow"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly And Co.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Eli Lilly",
                        "Report"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Dr. Reddy's Launches Atomoxetine Capsules, Generic Version Of Strattera, In U.S.",
                "features": {
                    "keywords": [
                        "Dr. Reddy's",
                        "Atomoxetine Capsules",
                        "Generic Version",
                        "Strattera",
                        "U.S."
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}